CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Symetis SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Symetis SA
Chemin de la venoge 11
Phone: +41 216510160p:+41 216510160 ECUBLENS, 1024  Switzerland Ticker: SYMSSYMS
This company was Merged or Acquired on 5/16/2017.
This is a Subsidiary, click here for the Parent Company
Business Summary
Symetis SA is a Switzerland-based company, which develops invasive transcatheter heart valve implantation devices to treat valvular heart diseases. The Company’s products, ACURATE TA and ACURATE neo and their delivery systems are based on proprietary design and delivery technologies. Its Symetis' Acurate Aortic Valve Replacement System offers an invasive solution for patients suffering from aortic valve stenosis. The Company provides Transcatheter aortic valve implantation (TAVI), which performs via a retrograde or antegrade approach and allows the valve delivery system through the stenotic aortic annulus via the femoral or subclavian arteries. The Company operates manufacturing sites in Ecublens, Switzerland and Belo Horizonte, Brazil; and its products are sold in the key markets oin Europe and in other markets. The Company receives funding from Endevour Vision SA.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201612/31/2016Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board of the Directors DominikEllenrieder 64 7/7/2016 7/7/2016
Chief Executive Officer, Board Member Jacques R.Essinger 61 1/1/2004
Chief Financial Officer KhaledBahi 51 10/1/2014 10/1/2014
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 103 (As of 12/31/2016)
Outstanding Shares: 4,699,977 (As of 12/31/2016)
Stock Exchange: EPA
Fax Number: +41 216510161


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023